Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-15

Clinical Trial Update: Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04208) [Phase 4]

View source ↗

Summary

Phase 4 crossover trial comparing patient preference between unscented Nasonex nasal spray and scented Flonase nasal spray for allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flonase (fluticasone propionate nasal spray)
  • Nasonex (mometasone furoate)

Snippet

Sponsor: Organon and Co | Conditions: Allergic Rhinitis | Phase 4 | Status: COMPLETED